Merck and Upsher-Smith agree to pay $60.2m in competition case

18-05-2017

Merck and Upsher-Smith Laboratories have agreed to pay $60.2 million in settlement fees to direct drug purchasers.


Merck, Upsher-Smith, anti-trust, competition, settlement, K-Dur 20, FTC, patent

LSIPR